Site Listing

Please choose the site that is most convenient for you

Study Name: A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic C
13 locations found